
Investing.com – France stocks were lower after the close on Wednesday, as losses in the Healthcare, Gas&Water and General Financial sectors led shares lower.
At the close in Paris, the CAC 40 lost 0.61%, while the SBF 120 index lost 0.57%.
The best performers of the session on the CAC 40 were Eurofins Scientific SE (EPA:EUFI), which rose 0.82% or 0.54 points to trade at 66.58 at the close. Meanwhile, WFD Unibail Rodamco NV (AS:URW) added 0.63% or 0.31 points to end at 49.40 and Teleperformance SE (EPA:TEPRF) was up 0.09% or 0.20 points to 222.20 in late trade.
The worst performers of the session were Engie SA (EPA:ENGIE), which fell 1.50% or 0.20 points to trade at 13.41 at the close. Alstom SA (EPA:ALSO) declined 1.43% or 0.33 points to end at 22.82 and Worldline SA (EPA:WLN) was down 1.38% or 0.51 points to 36.50.
The top performers on the SBF 120 were Carmila SA (EPA:CARM) which rose 2.45% to 13.36, Korian Medica SA (EPA:KORI) which was up 1.94% to settle at 9.46 and Eramet SA (EPA:ERMT) which gained 1.78% to close at 85.65.
The worst performers were Vallourec (EPA:VLLP) which was down 4.56% to 12.14 in late trade, Antin Infrastructure Partners SASU (EPA:ANTIN) which lost 2.62% to settle at 20.10 and Air France KLM SA (EPA:AIRF) which was down 2.61% to 1.25 at the close.
Falling stocks outnumbered advancing ones on the Paris Stock Exchange by 323 to 231 and 82 ended unchanged.
The CAC 40 VIX, which measures the implied volatility of CAC 40 options, was unchanged 0.00% to 18.96 a new 52-week high.
Gold Futures for February delivery was down 0.52% or 9.55 to $1,813.55 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in February fell 1.48% or 1.18 to hit $78.35 a barrel, while the March Brent oil contract fell 1.54% or 1.30 to trade at $83.38 a barrel.
EUR/USD was unchanged 0.09% to 1.06, while EUR/GBP unchanged 0.25% to 0.88.
The US Dollar Index Futures was up 0.15% at 104.05.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.